Search

Your search keyword '"van de Roemer, Niels"' showing total 18 results
Start Over Author "van de Roemer, Niels"
18 results on '"van de Roemer, Niels"'

1. Data from Exploiting the Mutanome for Tumor Vaccination

Author

Castle, John C., primary, Kreiter, Sebastian, primary, Diekmann, Jan, primary, Löwer, Martin, primary, van de Roemer, Niels, primary, de Graaf, Jos, primary, Selmi, Abderraouf, primary, Diken, Mustafa, primary, Boegel, Sebastian, primary, Paret, Claudia, primary, Koslowski, Michael, primary, Kuhn, Andreas N., primary, Britten, Cedrik M., primary, Huber, Christoph, primary, Türeci, Özlem, primary, and Sahin, Ugur, primary

Published
2023
Full Text
View/download PDF

2. Supplementary Table 2 from Exploiting the Mutanome for Tumor Vaccination

Author

Castle, John C., primary, Kreiter, Sebastian, primary, Diekmann, Jan, primary, Löwer, Martin, primary, van de Roemer, Niels, primary, de Graaf, Jos, primary, Selmi, Abderraouf, primary, Diken, Mustafa, primary, Boegel, Sebastian, primary, Paret, Claudia, primary, Koslowski, Michael, primary, Kuhn, Andreas N., primary, Britten, Cedrik M., primary, Huber, Christoph, primary, Türeci, Özlem, primary, and Sahin, Ugur, primary

Published
2023
Full Text
View/download PDF

3. Supplementary Methods from Exploiting the Mutanome for Tumor Vaccination

Author

Castle, John C., primary, Kreiter, Sebastian, primary, Diekmann, Jan, primary, Löwer, Martin, primary, van de Roemer, Niels, primary, de Graaf, Jos, primary, Selmi, Abderraouf, primary, Diken, Mustafa, primary, Boegel, Sebastian, primary, Paret, Claudia, primary, Koslowski, Michael, primary, Kuhn, Andreas N., primary, Britten, Cedrik M., primary, Huber, Christoph, primary, Türeci, Özlem, primary, and Sahin, Ugur, primary

Published
2023
Full Text
View/download PDF

4. Supplementary Table 1 from Exploiting the Mutanome for Tumor Vaccination

Author

Castle, John C., primary, Kreiter, Sebastian, primary, Diekmann, Jan, primary, Löwer, Martin, primary, van de Roemer, Niels, primary, de Graaf, Jos, primary, Selmi, Abderraouf, primary, Diken, Mustafa, primary, Boegel, Sebastian, primary, Paret, Claudia, primary, Koslowski, Michael, primary, Kuhn, Andreas N., primary, Britten, Cedrik M., primary, Huber, Christoph, primary, Türeci, Özlem, primary, and Sahin, Ugur, primary

Published
2023
Full Text
View/download PDF

11. Retraction Note: Improving usability and pregnancy rates of a fertility monitor by an additional mobile application: results of a retrospective efficacy study of Daysy and DaysyView app

Author

Koch, Martin C., primary, Lermann, Johannes, additional, van de Roemer, Niels, additional, Renner, Simone K., additional, Burghaus, Stefanie, additional, Hackl, Janina, additional, Dittrich, Ralf, additional, Kehl, Sven, additional, Oppelt, Patricia G., additional, Hildebrandt, Thomas, additional, Hack, Caroline C., additional, Pöhls, Uwe G., additional, Renner, Stefan P., additional, and Thiel, Falk C., additional

Published
2019
Full Text
View/download PDF

13. CIMT 2013

Author

Diken, Mustafa, Attig, Sebastian, Grunwitz, Christian, Kranz, Lena, Simon, Petra, van de Roemer, Niels, Vascotto, Fulvia, and Kreiter, Sebastian

Subjects
combination, cancer immunotherapy, immunomonitoring, CIMT, tumor microenvironment, cellular therapy, Meeting Report, tumor vaccination
Abstract

The 11th Annual Meeting of Association for Cancer Immunotherapy (CIMT) welcomed more than 700 scientists around the world to Mainz, Germany and continued to be the largest immunotherapy meeting in Europe. Renowned speakers from various fields of cancer immunotherapy gave lectures under CIMT2013’s tag: “Advancing targeted therapies” the highlights of which are summarized in this meeting report.

Published
2013

14. CIMT 2015: The right patient for the right therapy - Report on the 13th annual meeting of the Association for Cancer Immunotherapy

Author

Kranz, Lena M, primary, Birtel, Matthias, additional, Krienke, Christina, additional, Grunwitz, Christian, additional, Petschenka, Jutta, additional, Reuter, Kerstin C, additional, van de Roemer, Niels, additional, Vascotto, Fulvia, additional, Vormehr, Mathias, additional, Kreiter, Sebastian, additional, and Diken, Mustafa, additional

Published
2015
Full Text
View/download PDF

15. Erratum: Mutant MHC class II epitopes drive therapeutic immune responses to cancer

Author

Kreiter, Sebastian, primary, Vormehr, Mathias, additional, van de Roemer, Niels, additional, Diken, Mustafa, additional, Löwer, Martin, additional, Diekmann, Jan, additional, Boegel, Sebastian, additional, Schrörs, Barbara, additional, Vascotto, Fulvia, additional, Castle, John C., additional, Tadmor, Arbel D., additional, Schoenberger, Stephen P., additional, Huber, Christoph, additional, Türeci, Özlem, additional, and Sahin, Ugur, additional

Published
2015
Full Text
View/download PDF

17. Exploiting the Mutanome for Tumor Vaccination

Author

Castle, John C., primary, Kreiter, Sebastian, additional, Diekmann, Jan, additional, Löwer, Martin, additional, van de Roemer, Niels, additional, de Graaf, Jos, additional, Selmi, Abderraouf, additional, Diken, Mustafa, additional, Boegel, Sebastian, additional, Paret, Claudia, additional, Koslowski, Michael, additional, Kuhn, Andreas N., additional, Britten, Cedrik M., additional, Huber, Christoph, additional, Türeci, Özlem, additional, and Sahin, Ugur, additional

Published
2012
Full Text
View/download PDF

18. Improving usability and pregnancy rates of a fertility monitor by an additional mobile application: results of a retrospective efficacy study of Daysy and DaysyView app.

Author

Koch, Martin C., Lermann, Johannes, van de Roemer, Niels, Renner, Simone K., Burghaus, Stefanie, Hackl, Janina, Dittrich, Ralf, Kehl, Sven, Oppelt, Patricia G., Hildebrandt, Thomas, Hack, Caroline C., Pöhls, Uwe G., Renner, Stefan P., and Thiel, Falk C.

Subjects
BIOSENSORS, BIRTH rate, FERTILITY, PREGNANT women, RESEARCH evaluation, SURVEYS, UNSAFE sex, USER-centered system design, RETROSPECTIVE studies, MOBILE apps, HOME diagnostic tests, EQUIPMENT & supplies
Abstract

Background: Daysy is a fertility monitor that uses the fertility awareness method by tracking and analyzing the individual menstrual cycle. In addition, Daysy can be connected to the application DaysyView to transfer stored personal data from Daysy to a smartphone or tablet (IOS, Android). This combination is interesting because as it is shown in various studies, the use of apps is increasing patients´ focus on their disease or their health behavior. The aim of this study was to investigate if by the additional use of an App and thereby improved usability of the medical device, it is possible to enhance the typical-use related as well as the method-related pregnancy rates. Result: In the resultant group of 125 women (2076 cycles in total), 2 women indicated that they had been unintentionally pregnant during the use of the device, giving a typical-use related Pearl-Index of 1.3. Counting only the pregnancies which occurred as a result of unprotected intercourse during the infertile (green) phase, we found 1 pregnancy, giving a method-related Pearl-Index of 0.6. Calculating the pregnancy rate resulting from continuous use and unprotected intercourse exclusively on green days, gives a perfect-use Pearl-Index of 0.8. Conclusion: It seems that combining a specific biosensor-embedded device (Daysy), which gives the method a very high repeatable accuracy, and a mobile application (DaysyView) which leads to higher user engagement, results in higher overall usability of the method. [ABSTRACT FROM AUTHOR]

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results